G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan · Delayed Price · Currency is TWD 26.55
-0.05 (-0.19%)
Oct 30, 2026, 1:30 PM CST
G&E Herbal Biotechnology Market Cap
G&E Herbal Biotechnology has a market cap or net worth of 1.83 billion as of October 30, 2026. It is the 29,203rd most valuable company in the world and the 1,701st biggest in Taiwan. Its market cap has decreased by 37.06% in one year.
Market Cap
1.83B
Enterprise Value
1.40B
Revenue
215.61M
Global Rank
Country Rank
#1,701 Taiwan
PE Ratio
21.25
ChartMarket Cap Chart
Since April 28, 2008, G&E Herbal Biotechnology's market cap has decreased from 2.62B to 1.83B, a decrease of -30.24%. That is a compound annual growth rate of -1.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.83B | -33.16% |
| Dec 31, 2025 | 2.73B | -18.14% |
| Dec 31, 2024 | 3.34B | -2.92% |
| Dec 29, 2023 | 3.44B | 15.73% |
| Dec 30, 2022 | 2.97B | 90.71% |
| Dec 30, 2021 | 1.56B | -19.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3D Global Biotech | 2.37B |
| HeXun Biosciences | 2.28B |
| Taiwan Bio Therapeutics | 2.25B |
| Syngen Biotech | 2.15B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.08B |
| U-Neuron Biomedical | 1.77B |
| Anti-Microbial Savior BioteQ | 1.70B |
| Synbio Tech | 1.61B |